Paper93544
Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.
Thulesius O and 2 others. Eur J Clin Pharmacol, 1979. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins. Papers, record 93544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/93544
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dihydroergotamine | Major topic |
| Ethanolamines | Major topic |
| Etilefrine | Major topic |
| Midodrine | Major topic |
| Norepinephrine | Major topic |
| Phenylephrine | Major topic |
| Vasoconstrictor Agents | Major topic |
| Humans | |
| In Vitro Techniques | |
| Muscle, Smooth, Vascular | |
| Veins |
Source PubMed
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4600383 | [The pharmacological properties of Midodrin and its clinical application in patients with hypotensive circulatory disturbance (author's transl)]. | Wien Klin Wochenschr | 1974 | https://conductscience.org/library/papers/4600383 | PubMed |
| 2 | 56818 | [Treatment of hypotensive circular dysregulation using Gutron in practice]. | Wien Med Wochenschr | 1975 | https://conductscience.org/library/papers/56818 | PubMed |
| 3 | 788906 | Pathophysiological classification and diagnosis of orthostatic hypotension. | Cardiology | 1976 | https://conductscience.org/library/papers/788906 | PubMed |
| 4 | 66056 | Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite, ST 1059. | Arzneimittelforschung | 1976 | https://conductscience.org/library/papers/66056 | PubMed |
| 5 | 684381 | Physiological and pharmacological studies on isolated human bronchial preparations. | Scand J Respir Dis | 1978 | https://conductscience.org/library/papers/684381 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39944289 | Use of Midodrine for Intraoperative Hemostasis in Cutaneous and Percutaneous Surgery. | JID Innov | 2025 | https://conductscience.org/library/papers/39944289 | PubMed |
| 39102112 | Facile Integration of Hanztsch's Switch-Off/On Modeled Fluorogenic Probe for Feasible Tagging and Tracking of the Midodrine Drug in Different Matrices; First Evaluation of the Method's Greenness, Whiteness, Blueness, Quantum Yield, and Tablets' Content Homogeneity. | J Fluoresc | 2025 | https://conductscience.org/library/papers/39102112 | PubMed |
| 38047013 | Midodrine use in critically ill patients: a narrative review. | Crit Care Resusc | 2022 | https://conductscience.org/library/papers/38047013 | PubMed |
| 28011746 | The Pharmacology of Autonomic Failure: From Hypotension to Hypertension. | Pharmacol Rev | 2017 | https://conductscience.org/library/papers/28011746 | PubMed |
| 27271310 | Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine. | Hypertension | 2016 | https://conductscience.org/library/papers/27271310 | PubMed |
| 27169082 | Effect of Alpha-1-Adrenergic Agonist, Midodrine for the Management of Long-Standing Neurogenic Shock in Patient with Cervical Spinal Cord Injury: A Case Report. | Korean J Neurotrauma | 2015 | https://conductscience.org/library/papers/27169082 | PubMed |
| 9467688 | Midodrine. A review of its therapeutic use in the management of orthostatic hypotension. | Drugs Aging | 1998 | https://conductscience.org/library/papers/9467688 | PubMed |
| 6489409 | Pharmacological actions of the main metabolites of dihydroergotamine. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6489409 | PubMed |
| 6096723 | Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins. | Naunyn Schmiedebergs Arch Pharmacol | 1984 | https://conductscience.org/library/papers/6096723 | PubMed |
| 2480881 | Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. | Drugs | 1989 | https://conductscience.org/library/papers/2480881 | PubMed |
| 1712258 | Idiopathic orthostatic hypotension, midodrine, and anaesthesia. | Can J Anaesth | 1991 | https://conductscience.org/library/papers/1712258 | PubMed |
| 1349888 | Pharmacological analysis of positive chronotropic and inotropic responses to etilefrine in isolated dog heart preparations. | Heart Vessels | 1992 | https://conductscience.org/library/papers/1349888 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/93544
GET https://conductscience.org/api/papers/v1/93544/authors